Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001564590-23-003819
Filing Date
2023-03-16
Accepted
2023-03-16 17:12:00
Documents
5
Effectiveness Date
2023-03-16

Document Format Files

Seq Description Document Type Size
1 S-8 achv-s8.htm S-8 204461
2 EX-5.1 achv-ex51_9.htm EX-5.1 11713
3 EX-23.2 achv-ex232_8.htm EX-23.2 2689
4 EX-FILING FEES achv-exfilingfees_6.htm EX-FILING FEES 50143
5 GRAPHIC g2r2wc5fix10000001.jpg GRAPHIC 11818
  Complete submission text file 0001564590-23-003819.txt   286678
Mailing Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021
Business Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Filer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-270625 | Film No.: 23739747
SIC: 2835 In Vitro & In Vivo Diagnostic Substances